Resting State Electroencephalogram for Psychotic Disorders

Depression Clinical Trial

Official title:

Self-control, Appetite and Psychotic Diagnose: a Resting State EEG Cross Section Study

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05065489
• Other study ID #: WU2021EEG
• Status: Active, not recruiting
• Start date: September 1, 2021
• Est. completion date: December 1, 2023

Study information

• Verified date: November 2022
• Source: Central South University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Electroencephalography (EEG) has been proposed as a neurophysiological biomarker to delineate psychotic disorders. Meanwhile, the increased appetite, which might related to self-control process, has been an increasing concern for the management of psychotic disorders. In this cross-section study, investigators collect the resting state EEG data, self-control related scale, eating behaviour questionnaire and psychotic syndrome related assessement and try to find the connection between those measurers, in order to provide novel understanding on the mechanism of psychotic diseases.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 201
• Est. completion date: December 1, 2023
• Est. primary completion date: June 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 40 Years

Eligibility

Inclusion Criteria:

Diagnosed with schizophrenia or bipolar disorder or MDD in accordance with DMS-5 Informed Consent

Exclusion Criteria:

Diagnosed with other mental disease in accordance with DSM-5 Comorbid with other severe physiological disease Drug or alcohol abuse Pregnant or lactating

Related Conditions & MeSH terms

• Bipolar Disorder
• Depression
• Schizophrenia

Intervention

Other:
• No intervention
No intervention

Locations

Country	Name	City	State
China	Mental Health Institute of 2nd Xiangya Hospital,CSU	Changsha	Hunan

Sponsors (1)

Lead Sponsor	Collaborator
Central South University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	resting state EEG	resting state electroencephalography	baseline
Secondary	Three factor eating questionnaire	min value 21, max value 84. The higher scores mean more unhealthy eating behavior.	baseline
Secondary	Barratt Impulsivity Scale	min score 26, max score 104. The higher score means more impulsive.	baseline
Secondary	Self-Control Scale	min score 36, max score 180. The higher score means less self control.	baseline
Secondary	The positive and negative syndrome scale	min score 30, max score 210. The higher score means more severe symptoms.	baseline
Secondary	Hamilton anxiety rating scale	min score 14, max score 56. The higher score means more severe anxiety symptom	baseline
Secondary	Hamilton depression rating scale	min score 17, max score 68. The higher score means more severe depressive symptom	baseline
Secondary	Young manic rating scale	min score 0, max score 60, the higher score means more severe manic syndrome.	baseline